Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?

NCT00457405 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Ischemia-Reperfusion Injury
Atherosclerosis

Interventions

DRUG: dipyridamole

Sponsor

Radboud University Medical Center